Skip to main content
Kindstar Globalgene Technology, Inc. logo

Kindstar Globalgene Technology, Inc. — Investor Relations & Filings

Ticker · 9960 ISIN · KYG5262E1044 HKEX Human health and social work activities
Filings indexed 602 across all filing types
Latest filing 2023-07-10 Transaction in Own Shar…
Country HK Hong Kong
Listing HKEX 9960

About Kindstar Globalgene Technology, Inc.

http://www.kindstar.com.cn

Kindstar Globalgene Technology, Inc. is a leading independent provider of advanced specialty clinical testing services, specializing in esoteric testing. The company maintains the largest esoteric testing portfolio in its market, utilizing internationally-advanced laboratory facilities for clinical testing, scientific research, and applied R&D. Its comprehensive testing menu, featuring over 100 items, covers critical diagnostic areas including hematology, genetic diseases, gynecology, infectious diseases, neurology, and oncology. These services provide physicians and patients access to specialized diagnostics crucial for the diagnosis and treatment of major diseases.

Recent filings

Filing Released Lang Actions
Next Day Disclosure Returns
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks by Kindstar Globalgene Technology, Inc. It includes detailed information on repurchases of shares, dates, quantities, prices, and confirmations of compliance with listing rules on the Stock Exchange of Hong Kong. The content focuses on reporting share repurchase activities and changes in share capital, which aligns with announcements regarding share buybacks or capital changes. There is no indication that this is a full financial report, earnings release, or management discussion. The document is not a proxy statement, AGM material, or legal proceeding. Therefore, the document fits best under the category of 'Transaction in Own Shares' (POS), which covers reports of the company buying back or selling its own shares.
2023-07-10 English
Next Day Disclosure Returns
Transaction in Own Shares Classification · 95% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks by Kindstar Globalgene Technology, Inc. It details repurchases of shares on various dates, confirming compliance with listing rules of the Stock Exchange of Hong Kong. The content focuses on reporting share repurchase transactions and confirmations related to these capital changes. There are no financial statements, earnings data, or management discussions present. This type of document is a formal announcement of share repurchase activity, fitting the category of 'Transaction in Own Shares' (POS). The document length is over 11,000 characters, indicating it is a full disclosure rather than a brief announcement. Therefore, the appropriate classification is POS with high confidence.
2023-07-07 English
Next Day Disclosure Returns
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks by Kindstar Globalgene Technology, Inc. It details repurchases of shares on various dates, including quantities and prices, and confirms compliance with listing rules. The content focuses on share repurchase activities and disclosures required by the Stock Exchange of Hong Kong. There are no financial statements, earnings data, or management discussion. The document is a regulatory disclosure about share repurchases, fitting the description of a Transaction in Own Shares report rather than a full financial report or announcement of a report. Therefore, the appropriate classification is POS (Transaction in Own Shares).
2023-07-06 English
Next Day Disclosure Returns
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks by Kindstar Globalgene Technology, Inc. It details repurchases of shares on various dates, confirming compliance with listing rules and providing specifics on share repurchase transactions. The content focuses on reporting share repurchase activity rather than announcing a new share issue or capital change event. This aligns with the definition of 'Transaction in Own Shares' (POS), which covers reports of the company buying back or selling its own shares. The document is substantive and detailed, not merely an announcement or a brief notice, so it is not RPA or RNS. Therefore, the correct classification is POS.
2023-07-05 English
Next Day Disclosure Returns
Transaction in Own Shares Classification · 100% confidence The document is a Next Day Disclosure Return related to changes in issued share capital and share buybacks by Kindstar Globalgene Technology, Inc. It details repurchases of shares on specific dates, quantities, prices, and confirms compliance with listing rules. The document is a regulatory disclosure about share repurchases and capital changes, not a full financial report or earnings release. It fits the definition of a Transaction in Own Shares (POS) filing, which reports company buybacks or sales of its own shares.
2023-07-04 English
Next Day Disclosure Returns
Transaction in Own Shares Classification · 95% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks by Kindstar Globalgene Technology, Inc. It details repurchases of shares on specific dates, quantities, prices, and confirms compliance with listing rules. The content focuses on share repurchase activities and changes in issued shares, which aligns with announcements of share buybacks or capital changes. The document is about reporting these transactions rather than a full financial report or earnings release. Therefore, it fits the category of 'Transaction in Own Shares' (POS). The document length and detail support this classification with high confidence.
2023-07-03 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.